NCT00770965View on ClinicalTrials.gov

Phase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 10, 2008

Primary Completion Date

September 17, 2009

Study Completion Date

September 17, 2009

Conditions
Chronic Plaque Psoriasis
Interventions
BIOLOGICAL

AIN457

BIOLOGICAL

Placebo

Trial Locations (5)

16634

Novartis Investigative Site, Duncansville

27262

Novartis Investigative Site, High Point

37215

Novartis Investigative Site, Nashville

40217

Novartis Investigative Site, Louisville

90404

Novartis Investigative Site, Santa Monica

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY